Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 12-2017 | |
| Cash Flows From Operating Activities | ||
| Net Income | -89,491 | -69,852 |
| Depreciation Amortization | 1,535 | 432 |
| Income taxes - deferred | -500 | N/A |
| Accounts payable and accrued liabilities | 2,705 | N/A |
| Other Working Capital | 16,039 | 4,862 |
| Other Operating Activity | 5,124 | -1,823 |
| Operating Cash Flow | $-64,588 | $-66,381 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | -69,430 | N/A |
| PPE Investments | -5,366 | -2,742 |
| Net Acquisitions | -1,743 | -27,252 |
| Investing Cash Flow | $-76,539 | $-29,994 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 325 | N/A |
| Other Financing Activity | 14,215 | 271,182 |
| Financing Cash Flow | $14,540 | $271,182 |
| Beginning Cash Position | 188,921 | 14,114 |
| End Cash Position | 62,334 | 188,921 |
| Net Cash Flow | $-126,587 | $174,807 |
| Free Cash Flow | ||
| Operating Cash Flow | -64,588 | -66,381 |
| Capital Expenditure | -5,391 | N/A |
| Free Cash Flow | -69,979 | -66,381 |